Strobel S, Mowat A M, Ferguson A
Immunology. 1985 Sep;56(1):57-64.
Systemic hyporesponsiveness after ingestion of a protein antigen (oral tolerance) depends on antigen processing by the gut and the actions of immunoregulatory T cells. We have examined the effects of a graft-versus-host reaction (GvHR) on oral tolerance, since both immune status and intestinal function are altered in GvHR. The GvHR was induced in unirradiated (CBA X BALB/c)F1 mice by intraperitoneal injection of CBA spleen cells. The tolerance of systemic humoral immunity and of delayed-type hypersensitivity normally found in mice fed 25 mg ovalbumin (OVA) was partially abrogated from 1 to 3 weeks after induction of the GvHR. In addition, mice with GvHR had a persistent enhancement of systemic immunity to OVA, and this was associated with an augmented ability of spleen cells to present OVA to primed T cells. The phagocytic activity of the reticuloendothelial system, as established by carbon clearance tests, was not altered by the GvHR. These findings suggest that enhanced antigen-presenting cell activity interferes with the induction of oral tolerance, and may be another pathogenetic mechanism of intestinal hypersensitivity disease.
摄入蛋白质抗原后出现的全身低反应性(口服耐受)取决于肠道对抗原的处理以及免疫调节性T细胞的作用。我们研究了移植物抗宿主反应(GvHR)对口服耐受的影响,因为在GvHR中免疫状态和肠道功能都会发生改变。通过腹腔注射CBA脾细胞,在未受照射的(CBA×BALB/c)F1小鼠中诱导GvHR。在诱导GvHR后1至3周,正常情况下在喂食25mg卵清蛋白(OVA)的小鼠中发现的全身体液免疫耐受和迟发型超敏反应耐受被部分消除。此外,患有GvHR的小鼠对OVA的全身免疫持续增强,这与脾细胞将OVA呈递给致敏T细胞的能力增强有关。通过碳清除试验确定的网状内皮系统的吞噬活性并未因GvHR而改变。这些发现表明,增强的抗原呈递细胞活性会干扰口服耐受的诱导,并且可能是肠道超敏疾病的另一种发病机制。